0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Vitiligo - Epidemiology Forecast to 2032 - Product Thumbnail Image

Vitiligo - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Atopic Dermatitis (AD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Atopic Dermatitis (AD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Rosacea - Epidemiology Forecast to 2032 - Product Thumbnail Image

Rosacea - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Rosacea - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Rosacea - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
EUR$7,500USDGBP
From
EUR$7,500USDGBP
From
EUR$7,500USDGBP
Palmar Hyperhidrosis - Epidemiology Forecast to 2032 (US) - Product Thumbnail Image

Palmar Hyperhidrosis - Epidemiology Forecast to 2032 (US)

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$3,950USDGBP
Chronic Spontaneous Urticaria (CSU) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Spontaneous Urticaria (CSU) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • January 2022
  • 100 Pages
  • Global
From
EUR$5,700USDGBP
Contact Dermatitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Contact Dermatitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Chronic Inducible Urticaria Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Inducible Urticaria Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$2,975USDGBP
EUR$3,500USDGBP
From
EUR$2,975USDGBP
EUR$3,500USDGBP
From
EUR$2,975USDGBP
EUR$3,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$2,975USDGBP
EUR$3,500USDGBP
From
EUR$2,975USDGBP
EUR$3,500USDGBP
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more